Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: iProceedings

Date Submitted: May 5, 2022
Date Accepted: Dec 21, 2022

The final, peer-reviewed published version of this preprint can be found here:

Care Continuity, Telehealth Use, and Quality of Diabetes and Hypertension Care in Community Health Centers Before and During the COVID-19 Pandemic: Repeated Cross-sectional Study

Tierney AA, Payán DD, Brown T, Aguilera A, Shortell SM, Rodriguez HP

Care Continuity, Telehealth Use, and Quality of Diabetes and Hypertension Care in Community Health Centers Before and During the COVID-19 Pandemic: Repeated Cross-sectional Study

iProc 2023;9:e39306

DOI: 10.2196/39306

Care Continuity, Telehealth Use, and Quality of Diabetes and Hypertension Care in Community Health Centers Before and During the COVID-19 Pandemic: A repeated cross-sectional study

  • Aaron Alexander Tierney; 
  • Denise D. Payán; 
  • Timothy Brown; 
  • Adrian Aguilera; 
  • Stephen M. Shortell; 
  • Hector P. Rodriguez

ABSTRACT

Background:

Community health centers (CHCs) pivoted to remote chronic care services during COVID-19. While care continuity is associated with improved care quality and patients’ experiences, telehealth’s impact on these relationships is unclear.

Objective:

We examine the association between care continuity and telehealth use and quality of diabetes/hypertension care in CHCs before and during COVID-19.

Methods:

We collected electronic health record data from a cohort of n=20,792 diabetic and/or hypertensive patients with ≥2 visits/year from March-December 2019 and 2020 among 166 California CHCs in the OCHIN ADVANCE Collaborative. Logistic regression models estimated the association between care continuity (modified modified continuity index/MMCI) and telehealth adoption and blood pressure/hemoglobin A1c testing. Generalized linear regression models for 2019 and 2020 estimated the association between MMCI and blood pressure/A1c, exploring telehealth as a mediator.

Results:

Patients experienced reduced care continuity (2019: MMCI=0.71, SD=0.28, 2020: MMCI=0.63, SD=0.36; p<0.001) and more blood pressure (99.99% vs 99.75%) and A1c (53.38% vs 48.99%) assessments in 2019 vs 2020. Telehealth accounted for 0.33% of 2019’s visits and 9.55% of 2020’s. MMCI scores were associated with higher odds of telehealth use in 2020 (OR=1.96; p<0.001). MMCI (2019: OR=1.72, p<0.001; 2020: OR=1.66, p<0.001) and telehealth use (2019: OR=2.44, p<0.001; 2020: OR=6.82, p<0.001) were associated with greater A1c testing. MMCI was associated with lower A1c values in 2020 (-0.40, p=0.010), and lower systolic (2019: -1.64, p=0.045; 2020: -2.40, p=0.001) and diastolic (2019: -1.24, p=0.007; 2020: -1.33, p=0.001) blood pressure. MMCI and telehealth were not associated with A1c values in 2019. In 2020, telehealth mediated the relationship between MMCI and A1c testing (percent mediated=59%), but not MMCI and other study outcomes.

Conclusions:

Care continuity facilitates telehealth use and enables resilient performance on process measures. Elucidating how care continuity influences telehealth adoption may provide insights about implementing patient-centered innovations.


 Citation

Please cite as:

Tierney AA, Payán DD, Brown T, Aguilera A, Shortell SM, Rodriguez HP

Care Continuity, Telehealth Use, and Quality of Diabetes and Hypertension Care in Community Health Centers Before and During the COVID-19 Pandemic: Repeated Cross-sectional Study

iProc 2023;9:e39306

DOI: 10.2196/39306

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.